HTATIP2 and neoplasm: A tissue microarray, which consisted of clinical tumor samples from 43 patients with stage I–II NSCLC and 70 patients with stage III–IV NSCLC, was subjected to IHC to examine the protein expression levels of TIP30 in the tumors.